Breakpoints cover image

#69 – IDWeek 2022 Recap: Practice Changing Publications – Midnights Edition

Breakpoints

00:00

Putting the Fun in Fungi - A Fun Guide to New Antifungals

The Candicep trial is looking at beta D glucan guided antifungal therapy in intensive care medicine. This was a multi center randomized controlled trial between September 2016 through September 2019 they enrolled in 18 ICUs adult patients only. They only enrolled patients that had sepsis and had an increased risk of an invasive fungal infection so that would be risk factors like being on TPN having received broad spectrum antibiotics for more than 48 hours previously or having gastrointestinal surgery within the past seven days.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app